1. Search Result

Search Result

Targets Recommended: PAK

Results for "1438416-21-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-117474
    MJN110

    MAGL Neurological Disease
    MJN110 is an orally active and selective monoacylglycerol lipase (MAGL) inhibitor with IC50s of 9.1 nM and 2.1 nM for hMAGL and 2-arachidonoylglycerol (2-AG), respectively. MJN110 produces opioid-sparing effects and displays strong antihyperalgesic activity.